Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker LFCR
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Joshua Landes | 5.35M | 13.9% | SCHEDULE 13D/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Nelson Obus | 5.51M | 14.3% | SCHEDULE 13D/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Wynnefield Capital, Inc. | 1.02M | 2.7% | SCHEDULE 13D/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Wynnefield Capital Management, LLC | 3.96M | 10.3% | SCHEDULE 13D/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Wynnefield Capital, Inc. Profit Sharing & Money Purchase Plan | 367,350 | 1.0% | SCHEDULE 13D/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Wynnefield Small Cap Value Offshore Fund, Ltd. | 1.02M | 2.7% | SCHEDULE 13D/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Wynnefield Partners Small Cap Value, L.P. | 1.55M | 4.1% | SCHEDULE 13D/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Wynnefield Partners Small Cap Value, L.P. I | 2.41M | 6.3% | SCHEDULE 13D/A ↗ |
| Sep 28, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Raymond T. White | 6.99M | 17.3% | SCHEDULE 13D/A ↗ |
| Sep 28, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Christopher S. Kiper | 6.99M | 17.3% | SCHEDULE 13D/A ↗ |
| Sep 28, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners Holdings, LLC | 6.99M | 17.3% | SCHEDULE 13D/A ↗ |
| Sep 28, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners Asset Management, LLC | 6.99M | 17.3% | SCHEDULE 13D/A ↗ |
| Sep 28, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners, LLC | 6.91M | 17.1% | SCHEDULE 13D/A ↗ |
| Sep 28, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners, L.P. II | 537,406 | 1.4% | SCHEDULE 13D/A ↗ |
| Sep 28, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners, L.P. I | 6.38M | 15.9% | SCHEDULE 13D/A ↗ |
| Jul 29, 2026 | SCHEDULE 13G | LFCR Lifecore Biomedical, Inc. | BlackRock, Inc. | 2.01M | 5.4% | SCHEDULE 13G ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Nathaniel Calloway | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Bryson O. Hirai-Hadley | 583 | 0.0% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Aron R. English | 2.71M | 6.7% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW GP, Inc. | 2.71M | 6.7% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW Fund GP, LLC | 2.71M | 6.7% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW, LP | 2.71M | 6.7% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW Fund, LP | 2.71M | 6.7% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Raymond T. White | 6.79M | 17.1% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Christopher S. Kiper | 6.79M | 17.1% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners Holdings, LLC | 6.79M | 17.1% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners Asset Management, LLC | 6.79M | 17.1% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners, LLC | 6.72M | 16.9% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners, L.P. II | 520,263 | 1.4% | SCHEDULE 13D/A ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Legion Partners, L.P. I | 6.20M | 15.6% | SCHEDULE 13D/A ↗ |
| Apr 27, 2026 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | BlackRock, Inc. | 1.87M | 5.0% | SCHEDULE 13G/A ↗ |
| Jan 21, 2026 | SCHEDULE 13G | LFCR Lifecore Biomedical, Inc. | BlackRock, Inc. | 1.90M | 5.1% | SCHEDULE 13G ↗ |
| Oct 17, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | BlackRock, Inc. | 1.83M | 4.9% | SCHEDULE 13G/A ↗ |
| Jul 17, 2025 | SCHEDULE 13G | LFCR Lifecore Biomedical, Inc. | BlackRock, Inc. | 1.87M | 5.0% | SCHEDULE 13G ↗ |
| May 29, 2025 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Nathaniel Calloway | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| May 29, 2025 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Bryson O. Hirai-Hadley | 583 | 0.0% | SCHEDULE 13D/A ↗ |
| May 29, 2025 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | Aron R. English | 2.98M | 7.5% | SCHEDULE 13D/A ↗ |
| May 29, 2025 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW GP, Inc. | 2.98M | 7.5% | SCHEDULE 13D/A ↗ |
| May 29, 2025 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW Fund GP, LLC | 2.98M | 7.5% | SCHEDULE 13D/A ↗ |
| May 29, 2025 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW, LP | 2.98M | 7.5% | SCHEDULE 13D/A ↗ |
| May 29, 2025 | SCHEDULE 13D/A (amended) | LFCR Lifecore Biomedical, Inc. | 22NW Fund, LP | 2.98M | 7.5% | SCHEDULE 13D/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | Greenhaven Road Capital Fund 2, L.P. | 1.98M | 5.4% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | Greenhaven Road Capital Fund 1, L.P. | 1.63M | 4.4% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | Scott Miller | 3.62M | 9.8% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | MVM Funds, LLC | 3.62M | 9.8% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | Greenhaven Road Investment Management, L.P. | 3.62M | 9.8% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | Greenhaven Road Capital Fund 2, L.P. | 1.28M | 4.2% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | Greenhaven Road Capital Fund 1, L.P. | 1.09M | 3.6% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | Scott Miller | 2.37M | 7.8% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | LFCR Lifecore Biomedical, Inc. | MVM Funds, LLC | 2.37M | 7.8% | SCHEDULE 13G/A ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances